Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baloxavir and Oseltamivir in Immunocompromised Hosts with Influenza
NCT04712539Phase 2Recruiting
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Oct 2021
- Primary completion
- Feb 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of baloxavir marboxil in influenza, sponsored by University of Texas MD Anderson Cancer Center. Started Oct 2021; status: recruiting.
02
Drugs
baloxavir marboxil
03
Conditions
influenza
Beyond the preview
Go deeper on NCT04712539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04712539.